Gustafsson G, Lindstrm V, Rostami J et al (2017) Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
Venous hypertension and arterial hypotension and tachycardia, rapidly presented, which were collectively attenuated or counteracted, emphasize BPC 157s therapeutic effects (Vukojevic et al., 2018
Consequently, researchers have investigated whether supplementing glutathione or supporting its production might benefit individuals with liver conditions, including fatty liver disease, though evidence remains limited and such supplementation is not part of standard UK clinical practice
MalhotraAGrunsteinRRFietzeIWeaverTERedlineSAzarbarzinAet alTirzepatide for the treatment of obstructive sleep apnea and obesity
Novo Nordisks semaglutide, the GLP-1 analog used in Ozempic and Wegovy, showed an average weight loss of 10.6% at 68 weeks with the 2.4 mg dose in adults with type 2 diabetes and obesity or overweight in the STEP 2 Phase 3 trial
